The Centre’s renewed push for private hospital bill transparency has placed a familiar failure of India’s urban healthcare system back under scrutiny: patients are often told the total cost of treatment without being given enough information to understand how that figure was built. In West Bengal, the Health Commission is now considering whether hospitals should also disclose what they pay for medicines, medical equipment and consumables before charging patients.
The immediate trigger is a directive from the Union Health Ministry asking states to implement existing requirements on displaying charges for private hospital services. According to the report, hospitals are expected to put up clearly visible display boards showing the cost of different medical services. The boards must use lettering, colours and locations that allow patients and their families to notice the information easily.
The instruction has been sent to states by Union Health Secretary Punya Salila Srivastava. Health services fall under the Concurrent List, allowing both the Centre and states to legislate and regulate in the sector. The Centre’s intervention therefore seeks to revive and standardise provisions that states were already expected to enforce under the Clinical Establishments Act framework.
That distinction is important. The latest direction is not presented as an entirely new consumer-protection law. The report states that a notification issued in 2012 under the Clinical Establishments Act had already required private hospitals to disclose the charges imposed for different components of medical treatment. West Bengal introduced its own Clinical Establishments Act in 2017 and subsequently created a Health Commission to hear complaints against private healthcare providers.
The question now is why a fresh directive was considered necessary more than a decade after the original framework was notified. The answer suggested by the continuing complaints is that disclosure on paper has not necessarily translated into usable information at the hospital counter, billing desk or emergency ward. A regulation that exists but is not visible, enforceable or understood by patients leaves the information imbalance largely unchanged.
Private healthcare has become an important part of the urban health system, particularly in cities where hospitals provide specialised treatment, emergency care and high-end diagnostic services. Families entering these facilities are often making decisions under intense time pressure. They may not be able to compare rates, question each item or understand whether a charge refers to a doctor’s service, a procedure, a medicine, a device or a hospital consumable.
A display board can address only one part of that problem. It may tell a family what a service is supposed to cost, but it does not automatically explain whether the hospital has added a separate charge for equipment, nursing, consumables, administrative services or a package component. Nor does a board, by itself, establish whether the rate displayed at admission will remain the same when treatment becomes more complicated.
The West Bengal Health Commission’s consideration of a broader disclosure model is therefore more significant than the display-board requirement alone. The report says the Commission is examining models used in Uttar Pradesh and Karnataka, under which hospitals may be asked to disclose the price at which they purchase medicines, medical equipment and consumables and the amount charged to patients.
In Karnataka, a directive from the state’s Food and Drugs Administration reportedly required private hospitals to mention in bills the wholesale price at which medicines, medical equipment and other materials were purchased, along with the maximum retail price charged to patients. The report also refers to a similar approach in Uttar Pradesh. West Bengal officials are considering whether such a system can be introduced in the state.
The proposed shift is from service-price disclosure to transaction-level transparency. That matters because many medical bills contain items that patients cannot easily evaluate. A family may know the name of a procedure but not whether the price of a glove, syringe, tube or dressing is reasonable. If the purchase price and the amount billed are visible, regulators and patients would at least have a clearer basis for identifying unusually large mark-ups.
The report cites examples from an earlier Anandabazar.com investigation into private healthcare pricing in West Bengal. It said a pair of surgical gloves costing Rs 19 in the wholesale market was being billed at Rs 80 in private hospitals. A syringe priced at Rs 21.72 in the wholesale market was reportedly charged at Rs 199.49, while a Ryle’s tube costing Rs 15.55 was listed at an MRP of Rs 86 on a private hospital bill.
These examples are presented by the source as evidence of the pricing gap, not as a comprehensive survey of all hospitals in West Bengal. They nevertheless illustrate the institutional problem facing regulators. Without a standardised bill format and access to supporting price information, it becomes difficult for a patient to distinguish between a legitimate hospital charge, a manufacturer’s MRP, a procurement cost and a mark-up imposed within the hospital’s supply chain.
The concern has also appeared in other states. The report refers to comments by Tukaram Mundhe, Commissioner of Maharashtra’s Food and Drug Administration, who alleged on his X account in September that commonly used hospital consumables were being sold to patients at prices as much as 2,841 per cent above their purchase cost. The report does not provide a separate regulatory finding on each item, but the allegation added to the national debate over hospital billing.
For West Bengal, the unresolved issue is not the absence of a regulatory institution. The state has a statutory framework and a Health Commission empowered to hear complaints. The newly constituted Commission, led by retired judge Biswajit Basu, held its first hearing on Tuesday and heard seven cases, according to the report.
Basu said the Commission was trying to reduce complaints about private hospital services but added that the overall system was not satisfactory and required substantial improvement. He said patients were not receiving all the facilities to which they were entitled in many cases, and that the Commission had a responsibility to bring about change.
The Commission’s comments point to a wider governance challenge. Complaint resolution is necessary, but it is a reactive mechanism: a patient must first endure a disputed bill, collect documents and approach the regulator. Transparent pricing is intended to move some protection earlier in the process, before a family accepts treatment or receives a final invoice.
However, transparency becomes meaningful only when the information is comparable and enforceable. Hospitals would need to identify charges consistently, explain revisions to estimates, record procurement and billing prices accurately, and provide itemised invoices that patients can understand. Regulators would also need the capacity to inspect records, investigate complaints and impose consequences when disclosure requirements are ignored.
The All India Drugs Action Network’s joint convenor Malini Aisola, quoted in the report, said that private hospitals often communicate package rates rather than the cost of each stage of treatment. In that system, families may struggle to determine whether they have been charged twice for the same service. She described the Centre’s direction as a positive step but said states must take effective action to bring hospital practices within the law.
That observation captures the difference between a visible rate card and genuine bill transparency. A package may simplify payment for some patients, but it can also conceal the individual components of treatment. If the package changes during a procedure, or if additional items are added, the patient needs a clear record of what triggered the extra cost and who authorised it.
The Health Commission’s proposal to disclose procurement and sale prices would create a more detailed accountability trail. Commission member and doctor Narayan Bandyopadhyay said, according to the report, that hospitals make significant profits from medicines, cotton, bandages and similar supplies, and that knowing the scale of those profits would help determine the next steps. Basu said the Commission could recommend that the state government require hospitals to disclose their purchase and sale prices.
The policy challenge is to design disclosure rules that are strong enough to expose unjustified charges without creating a confusing or unusable document for patients. A bill that lists every item but uses technical descriptions, inconsistent units or unclear pricing categories may satisfy a formal requirement while remaining inaccessible to ordinary families.
The evidence in the report confirms three things. First, West Bengal already has a legal and institutional framework for regulating private clinical establishments. Second, complaints about billing and service standards continue despite that framework. Third, the state is now considering a more granular model in which procurement prices and patient charges are disclosed together.
What remains uncertain is whether the Centre’s direction will be backed by a clear implementation schedule, standard formats, inspections and penalties. It is also not established in the supplied material whether West Bengal has formally adopted the proposed procurement-price disclosure model. The next important step will be the Health Commission’s recommendation to the state Health Department and the government’s decision on whether to convert that recommendation into an enforceable rule.
The larger urban question is whether patients can be treated as informed consumers when medical care is purchased under emergency conditions and when the supplier controls much of the information. Display boards may make prices more visible. Only consistent itemised billing, verifiable procurement records and active enforcement can determine whether that visibility reduces the power imbalance behind the bill.
